Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
70,292.00
(
-0.32%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: randychub post# 12037

Friday, 06/10/2005 10:25:33 AM

Friday, June 10, 2005 10:25:33 AM

Post# of 257268
>>Also the CD137 cancer drug being developed for the MAYO clinic. Would gtcb manufactoring this drug be similiar to gtcb manufactoring avastin or erbitux?<<

GTC could manufacture mAb’s such as Avastin and Erbitux, but I think it’s unlikely they will. GTC is focusing on plasma proteins and difficult-to-express proteins, where their production method offers the greatest benefit in safety, yield, or even feasibility relative to conventional production methods.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today